The present analysis showed, for the first time, that the anti-tumor effect of fisetin was mediated mainly through activation of CDKN1A, SEMA3E, GADD45B and GADD45A and down-regulation of TOP2A, KIF20A, CCNB2 and CCNB1 genes. This evidence concerns the gene SEMA3E and neoplasm.